BITNEWS

Truist Financial Lowers Genmab A/S (NASDAQ:GMAB) Price Target to $45.00

Genmab A/S (NASDAQ:GMAB – Get Free Report) had its price target reduced by analysts at Truist Financial from $50.00 to $45.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 122.66% from the company’s [...]

ONLY AVAILABLE IN PAID PLANS

Published by: defenseworld

Read full article here: https://www.defenseworld.net/2025/03/13/truist-financial-lowers-genmab-a-s-nasdaqgmab-price-target-to-45-00.html